The sCD13 protein has been previously identified by a rheumatology research team at the University of Michigan as a powerful inducer of inflammation in multiple autoimmune disorders, such as ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

In April 2025, Areteia Therapeutics announced a study will assess the efficacy and safety of dexpramipexole as an adjunctive ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

According to a new study published in JAMA ,calprotectin may serve as a mechanistically informed biomarker for ...

How your immune system really ages — research shows aging brings adaptation not decline and reveals ways to maintain immune ...

Protalix BioTherapeutics, Inc. (AMEX: PLX) Q1 2025 Earnings Call Transcript May 9, 2025 Protalix BioTherapeutics, Inc. misses ...

Machine learning identifies key biomarkers predicting hydroxyurea resistance in polycythemia vera, enhancing early treatment ...

Why Should Inflammation Be a Focus? Inflammation plays a central role in the development and progression of chronic ...

Prediabetes silently harms your heart, brain, eyes and more long before diabetes develops. Learn the hidden dangers of this ...

"It's a momentous breakthrough for families facing this devastating disease," said Dr. Claire Booth, leader of the London ...

Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...